Medicine and Dentistry
Patient
100%
Cardiovascular System
44%
Inpatient
37%
Therapeutic Procedure
36%
Cardiovascular Disease
31%
Maturity Onset Diabetes of the Young
30%
Combination Therapy
25%
Arteriosclerosis Obliterans
25%
Acute Kidney Injury
23%
Chemotherapeutic Agent
20%
Drug
20%
Sodium Glucose Cotransporter 2 Inhibitor
20%
Heart
18%
Cardiovascular Risk
18%
Heart Failure
18%
Diseases
17%
Complication
15%
Mortality
15%
Revascularization
14%
Empagliflozin
14%
COVID-19
14%
Glucose
14%
Association
14%
Incidence
14%
Analysis
14%
Development
13%
Critical Limb Ischemia
13%
Chronic Kidney Disease
13%
Diabetes Mellitus
12%
Blood Pressure
12%
Patient with Type 2 Diabetes
11%
Age
11%
Stent
10%
Atherectomy
10%
Experience
9%
Placebo
9%
Odds Ratio
9%
Calcium Ion
8%
Clinical Trial
8%
Hypertension
8%
Myocardial Infarction
8%
Lesion
8%
Diabetes
8%
Meta-Analysis
8%
Evaluation Study
8%
Percutaneous Coronary Intervention
8%
Diagnosis
8%
Arterial Stiffness
8%
Pioglitazone
8%
Obesity
7%
Coronary Artery Disease
7%
Woman
7%
Comprehension
7%
Follow up
7%
Amputation
7%
Hypertrophic Cardiomyopathy
7%
Nephropathy
7%
Apoplexy
7%
Limb
7%
Adult
7%
Angiography
6%
Physician
6%
Lung
6%
Hypoglycemia
6%
Exercise
6%
Cardiac Dysrhythmia
6%
Insulin Resistance
6%
Contrast Medium
6%
Motivation
6%
Catheter
6%
Atherosclerosis
6%
Lipid
6%
Acetylsalicylic Acid
6%
Risk Reduction
6%
Morbidity
6%
Injury
6%
Measurement
6%
Kidney
6%
Pulse Wave Velocity
5%
Magnesium Ion
5%
Lifespan
5%
Propranolol
5%
Introspection
5%
Chronic Total Occlusion
5%
Pulse Pressure
5%
Optical Coherence Tomography
5%
Aptitude
5%
Metabolism
5%
Glucagon-Like Peptide-1 Agonist
5%
Myocardium
5%
Survival
5%
Health
5%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
5%
Receptor
5%
Hyperglycemia
5%
Pathophysiology
5%
Patient with Diabetes
5%
Isotopes of Calcium
5%
Embolization
5%
Systematic Review
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
16%
Sodium Glucose Cotransporter 2 Inhibitor
15%
Empagliflozin
14%
Cardiovascular Risk
11%
Heart Infarction
11%
Glucose
9%
Clinical Trial
8%
Drug
8%
Acetylsalicylic Acid
8%
Diabetes Mellitus
7%
Rivaroxaban
6%
Death
6%
Heart Failure
5%
Mortality
5%
Breast Cancer
5%
Diseases
5%
Lipoprotein
5%
Biochemistry, Genetics and Molecular Biology
Uniporter
18%
Calcium
17%
Association
12%
Bioenergy
7%
Dynamics
7%
Protein
7%
Mitochondrion
6%
Regulatory Mechanism
6%
Atrial Fibrillation
6%
Mouse
6%
Phospholipid
6%
Age
5%
Homeostasis
5%
Health
5%
Lipid
5%